5 Days Ago
1 Min Read

What to expect when you're expecting LPTX's upcoming earnings report:

+7.34% 24h

We're just a few days out from Leap Therapeutics Inc (LPTX) reporting earnings. Lets take a look at how this biotech is doing.

Analysts think Leap Therapeutics Inc will clock in with an EPS (earnings per share) of around 
-$0.10. Over the last 90 days, analysts have lowered estimates once and raised them four times, signaling a bullish move.

Shares of LPTX were trading at $1.15 as of August 04. Over the last 52-weeks, shares are down -72.42%. A larger percentage here can mean investors have a stronger bullish or bearish outlook on the stock.

There are three primary things that LPTX bulls will be concerned with. The first is that the reported EPS beat analysts estimates. The second is that the beat is on higher than expected revenues. Third, that the company guides analysts to robust growth going forward. If all check out, the stock should react accordingly.

If you're a bear you'll primarily care about two things. The first is that the reported EPS underperformed analysts estimates. The stock should move on just that news alone. The second is that the report paints a pretty depressing picture of how the company will decelerate or even see a decline in revenues over the following quarters. EPS underperformance, and a negative growth story, those are the things to watch.

Regardless of which side of the fence you're on, it's important to note that sometimes the company's earnings report plays less of a role in moving the price than the analysts' estimates. This can be caused by a change in the analysts' estimates based on the Q&A from the conference call with management discussing the earnings report.